ArticleNature reviews. Nephrology2019
Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.
Abstract readPublished Erratum
In one paragraph
Article in Nature reviews. Nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Intratubular light chain amyloidosis: a comprehensive analysis of disease spectrum and clinicopathological characteristics.Clinical kidney journal · 2026Article
- Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma.Journal of personalized medicine · 2023Review
- Proliferative glomerulonephritis with monoclonal IgG deposits: a unique case with a clinical course of over 46 years.BMC nephrology · 2023Article
- Immunoglobulin M Paraproteinaemias.Cancers · 2020Review
- Monoclonal Gammopathy of Undetermined Significance (MGUS)-Not So Asymptomatic after All.Cancers · 2020Review
- Membranoproliferative glomerulonephritis with deposition of monoclonal IgG evolved from polyclonal IgG: a case report with two consecutive renal biopsies.BMC nephrology · 2019Article
Corrections and comments
- Erratum for
Authors and funding
33 authors.
Nelson LeungDivision of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. leung.nelson@mayo.edu.
Frank BridouxDepartment of Nephrology, Centre Hospitalier Universitaire et Université de Poitiers, Poitiers, France; CNRS UMR7276, Limoges, France; and Centre de Référence Amylose AL et Autres Maladies par Dépôt d'Immunoglobulines Monoclonales, Poitiers, France.
Vecihi BatumanVeterans Administration Medical Center, New Orleans, LA, USA and Tulane University Medical School, Tulane, LA, USA.
Aristeidis ChaidosCentre for Haematology, Department of Medicine, Imperial College London and Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
Paul CockwellDepartment of Nephrology, Renal Medicine - University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK.
Vivette D D'AgatiDepartment of Pathology, Renal Pathology Laboratory, Columbia University, College of Physicians and Surgeons, New York, NY, USA.
Angela DispenzieriDivision of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Fernando C FervenzaDivision of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Jean- Paul FermandDepartment of Haematology and Immunology, University Hospital St Louis, Paris, France.
Simon GibbsThe Victorian and Tasmanian Amyloidosis Service, Department of Haematology, Monash Univerity Easter Health Clinical School, Melbourne, Victoria, Australia.
Julian D GillmoreNational Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Royal Free Campus, University College London, London, UK.
Guillermo A HerreraDepartment of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
Arnaud JaccardService d'Hématologie et de Thérapie Cellulaire, Centre de Référence des Amyloses Primitives et des Autres Maladies par Dépôts d'Immunoglobuline, CHU Limoges, Limoges, France.
Dragan JevremovicDivision of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Efstathios KastritisDepartment of Clinical Therapeutics, School of Medicine National and Kapodistrian University of Athens Alexandra Hospital, Athens, Greece.
Vishal KukretiUniversity Health Network, Princess Margaret Cancer Centre, Toronto, Canada.
Robert A KyleDivision of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Helen J LachmannNational Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Royal Free Campus, University College London, London, UK.
Christopher P LarsenArkana Laboratories, Little Rock, AR, USA.
Heinz LudwigWilhelminen Cancer Research Institute, Wilhelminenspital, Vienna, Austria.
Glen S MarkowitzDepartment of Pathology, Renal Pathology Laboratory, Columbia University, College of Physicians and Surgeons, New York, NY, USA.
Giampaolo MerliniAmyloidosis Research and Treatment Center, IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
Peter MolleeHaematology Department, Princess Alexandra Hospital and School of Medicine, University of Queensland, Brisbane, Australia.
Maria M PickenDepartment of Pathology, Loyola University Medical Center, Maywood, IL, USA.
Vincent S RajkumarDivision of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Virginie RoyalDepartment of Pathology, Hôpital Maisonneuve- Rosemont, Université de Montreal, Montreal, Quebec, Canada.
Paul W SandersDepartment of Medicine, University of Alabama at Birmingham and Department of Veterans Affairs Medical Center, Birmingham, AL, USA.
Sanjeev SethiDivision of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Christopher P VennerCross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada.
Peter M VoorheesDepartment of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium System, Charlotte, NC, USA.
Ashutosh D WechalekarNational Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Royal Free Campus, University College London, London, UK.
Brendan M WeissAbramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
Samih H NasrDivision of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Funding
Low Molecular Weight Protein NephrotoxicityI01BX001192 · VA · BIRMINGHAM VA MEDICAL CENTER · PI SANDERS, PAUL W. · 2011 to 2014
–Low Molecular Weight Protein NephrotoxicityI01CX001326 · VA · BIRMINGHAM VA MEDICAL CENTER · PI SANDERS, PAUL W. · 2015 to 2024
–BLRD VA I01 BX001192CSRD VA I01 CX001326
Abstract
In the key to Figure 1 of this article, 'Amyloid microtubules' has been corrected to 'Microtubules'.
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.